{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:58:17Z","timestamp":1771048697257,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.avsg.2022.04.039","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T03:26:00Z","timestamp":1652239560000},"page":"1-8.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Systematic Review and Meta-analysis of the Outcomes of Drug-Eluting Stent Versus Drug-Coated Balloon Angioplasty for Lower Extremity Peripheral Artery Diseases"],"prefix":"10.1016","volume":"85","author":[{"given":"Jiarong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-5880","authenticated-orcid":false,"given":"Wayne W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2022.04.039_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2022.04.039_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.04.039_bib3","first-page":"CD012510","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries","volume":"1","author":"Kayssi","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.avsg.2022.04.039_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jcin.2018.02.019","article-title":"Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the IN.PACT global study","volume":"11","author":"Micari","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.04.039_bib5","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1253\/circj.CJ-18-0077","article-title":"Drug-coated balloon vs. conventional balloon angioplasty in dialysis patients with symptomatic femoropopliteal disease \u2014 a matched comparison","volume":"82","author":"Chou","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.avsg.2022.04.039_bib6","doi-asserted-by":"crossref","first-page":"e006321","DOI":"10.1161\/JAHA.117.006321","article-title":"ISAR-PEBIS (Paclitaxel-Eluting balloon versus conventional balloon angioplasty for in-stent restenosis of superficial femoral artery): a randomized trial","volume":"6","author":"Ott","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2022.04.039_bib7","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jcin.2016.04.012","article-title":"Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial","volume":"9","author":"Kinstner","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.04.039_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.04.039_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2022.04.039_bib10","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2022.04.039_bib11","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.04.039_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.119.040518","article-title":"Mortality assessment of paclitaxel-coated balloons: patient-level meta-analysis of the ILLUMENATE clinical program at 3 years","volume":"140","author":"Gray","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.04.039_bib13","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.04.039_bib14","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.04.039_bib15","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)","volume":"41","author":"Giacoppo","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2022.04.039_bib16","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.avsg.2022.04.039_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.avsg.2022.04.039_bib18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2753.2008.00986.x","article-title":"Interpretation of tests of heterogeneity and bias in meta-analysis","volume":"14","author":"Ioannidis","year":"2008","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.avsg.2022.04.039_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1583\/13-4630MR.1","article-title":"Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions","volume":"21","author":"Zeller","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2022.04.039_bib20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.avsg.2022.04.039_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.avsg.2019.05.013","article-title":"Amputation-free survival in patients with critical limb ischemia treated with paclitaxel-eluting stents and paclitaxel-coated balloons","volume":"62","author":"Phair","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2022.04.039_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2019.04.057","article-title":"Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study","volume":"74","author":"Liistro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.04.039_bib23","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1093\/eurheartj\/ehz698","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","volume":"41","author":"Freisinger","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2022.04.039_bib24","doi-asserted-by":"crossref","first-page":"e008528","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","article-title":"Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the vascular quality initiative","volume":"13","author":"Bertges","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.04.039_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.04.039_bib26","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.04.039_bib27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2022.04.039_bib28","first-page":"139","article-title":"Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: an updated meta-analysis of randomized controlled trials","volume":"94","author":"Anantha-Narayanan","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.04.039_bib29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/CIRCULATIONAHA.119.041099","article-title":"Paclitaxel-coated balloons and eluting stents: is there a mortality risk in patients with peripheral artery disease?","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.04.039_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eclinm.2019.09.004","article-title":"Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: a systematic review and meta-analysis of randomised controlled trials","volume":"16","author":"Klumb","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.avsg.2022.04.039_bib31","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.04.039_bib32","doi-asserted-by":"crossref","first-page":"e83992","DOI":"10.1371\/journal.pone.0083992","article-title":"In\u00a0vitro determination of drug transfer from drug-coated balloons","volume":"8","author":"Seidlitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2022.04.039_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejpb.2015.08.010","article-title":"In\u00a0vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons","volume":"96","author":"Kempin","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.avsg.2022.04.039_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0b013e31820577df","article-title":"Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model","volume":"46","author":"Kelsch","year":"2011","journal-title":"Invest Radiol"},{"key":"10.1016\/j.avsg.2022.04.039_bib35","doi-asserted-by":"crossref","first-page":"17220","DOI":"10.1038\/s41598-020-74227-1","article-title":"Systematic evaluation of particle loss during handling in the percutaneous transluminal angioplasty for eight different drug-coated balloons","volume":"10","author":"Heinrich","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.avsg.2022.04.039_bib36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2015.03.020","article-title":"Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: a comparative drug-coated balloon study in the Familial hypercholesterolemic swine model of superficial femoral in-stent restenosis","volume":"8","author":"Gongora","year":"2015","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622002254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622002254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:05:47Z","timestamp":1760187947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509622002254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":36,"alternative-id":["S0890509622002254"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2022.04.039","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review and Meta-analysis of the Outcomes of Drug-Eluting Stent Versus Drug-Coated Balloon Angioplasty for Lower Extremity Peripheral Artery Diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2022.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}